Ras C-terminal processing enzymes--new drug targets?
Gibbs
J B
JB
Department of Cancer Research, Merck Sharp and Dohme Research Laboratories, West Point, Pennsylvania 19486.
D019883:Alkyl and Aryl Transferases; D000595:Amino Acid Sequence; D000818:Animals; D006801:Humans; D008969:Molecular Sequence Data; D009369:Neoplasms / Q000188:drug therapy; D015689:Oncogene Protein p21(ras) / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D011499:Protein Processing, Post-Translational; D016283:Proto-Oncogene Proteins p21(ras) / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D014166:Transferases / Q000037:antagonists & inhibitors / Q000378:metabolism
D014166:Transferases; D019883:Alkyl and Aryl Transferases; C064911:p21(ras) farnesyl-protein transferase; C501009:HRAS protein, human; D015689:Oncogene Protein p21(ras); D016283:Proto-Oncogene Proteins p21(ras)